- cafead   Sep 14, 2014 at 11:53: AM
The most clicked news item from Friday's front page news was this Yahoo/Reuters piece:
Gilead to raise price for new hepatitis C drug above $84,000
Although Gilead is already under fire for it's current price tag of $84,000, it is planning on raising the price of the treatment to a higher unspecified amount.
The article discusses predictions for the new higher cost, plus the claim that the treatment will actually be shortened, and therefore less expensive over the life of the treatment, at least for some patients.
What is your opinion on the pricing plan?
Gilead to raise price for new hepatitis C drug above $84,000
Although Gilead is already under fire for it's current price tag of $84,000, it is planning on raising the price of the treatment to a higher unspecified amount.
The article discusses predictions for the new higher cost, plus the claim that the treatment will actually be shortened, and therefore less expensive over the life of the treatment, at least for some patients.
What is your opinion on the pricing plan?